Logo image of ELES.MI

ELES SEMICONDUCTOR EQUIPMENT (ELES.MI) Stock Fundamental Analysis

Europe - BIT:ELES - IT0005373417 - Common Stock

2.23 EUR
-0.07 (-3.04%)
Last: 9/16/2025, 7:00:00 PM
Fundamental Rating

5

Overall ELES gets a fundamental rating of 5 out of 10. We evaluated ELES against 56 industry peers in the Semiconductors & Semiconductor Equipment industry. ELES has only an average score on both its financial health and profitability. ELES is not priced too expensively while it is growing strongly. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

ELES had positive earnings in the past year.
In the past year ELES had a positive cash flow from operations.
In the past 5 years ELES has always been profitable.
ELES had a positive operating cash flow in 4 of the past 5 years.
ELES.MI Yearly Net Income VS EBIT VS OCF VS FCFELES.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M

1.2 Ratios

ELES has a Return On Assets of 2.24%. This is in the lower half of the industry: ELES underperforms 77.78% of its industry peers.
With a Return On Equity value of 4.47%, ELES is not doing good in the industry: 74.07% of the companies in the same industry are doing better.
ELES has a Return On Invested Capital (6.98%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for ELES is significantly below the industry average of 14.85%.
The 3 year average ROIC (4.69%) for ELES is below the current ROIC(6.98%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.24%
ROE 4.47%
ROIC 6.98%
ROA(3y)1.61%
ROA(5y)2.47%
ROE(3y)3.53%
ROE(5y)5.33%
ROIC(3y)4.69%
ROIC(5y)4.15%
ELES.MI Yearly ROA, ROE, ROICELES.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

ELES has a Profit Margin of 3.48%. This is in the lower half of the industry: ELES underperforms 79.63% of its industry peers.
ELES's Profit Margin has declined in the last couple of years.
ELES has a Operating Margin (12.08%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of ELES has grown nicely.
ELES has a Gross Margin of 51.40%. This is in the better half of the industry: ELES outperforms 66.67% of its industry peers.
In the last couple of years the Gross Margin of ELES has grown nicely.
Industry RankSector Rank
OM 12.08%
PM (TTM) 3.48%
GM 51.4%
OM growth 3Y29.01%
OM growth 5Y12.15%
PM growth 3Y-8.14%
PM growth 5Y-6.16%
GM growth 3Y11.8%
GM growth 5Y5.73%
ELES.MI Yearly Profit, Operating, Gross MarginsELES.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ELES is destroying value.
ELES has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ELES has more shares outstanding
The debt/assets ratio for ELES has been reduced compared to a year ago.
ELES.MI Yearly Shares OutstandingELES.MI Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ELES.MI Yearly Total Debt VS Total AssetsELES.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

ELES has an Altman-Z score of 2.44. This is not the best score and indicates that ELES is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.44, ELES is not doing good in the industry: 72.22% of the companies in the same industry are doing better.
The Debt to FCF ratio of ELES is 2.75, which is a good value as it means it would take ELES, 2.75 years of fcf income to pay off all of its debts.
ELES's Debt to FCF ratio of 2.75 is in line compared to the rest of the industry. ELES outperforms 48.15% of its industry peers.
A Debt/Equity ratio of 0.34 indicates that ELES is not too dependend on debt financing.
ELES has a worse Debt to Equity ratio (0.34) than 62.96% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 2.75
Altman-Z 2.44
ROIC/WACC0.69
WACC10.04%
ELES.MI Yearly LT Debt VS Equity VS FCFELES.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M 20M 25M

2.3 Liquidity

A Current Ratio of 2.33 indicates that ELES has no problem at all paying its short term obligations.
With a Current ratio value of 2.33, ELES perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
ELES has a Quick Ratio of 1.79. This is a normal value and indicates that ELES is financially healthy and should not expect problems in meeting its short term obligations.
ELES has a Quick ratio (1.79) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.33
Quick Ratio 1.79
ELES.MI Yearly Current Assets VS Current LiabilitesELES.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 64.37% over the past year.
Measured over the past 5 years, ELES shows a small growth in Earnings Per Share. The EPS has been growing by 0.68% on average per year.
Looking at the last year, ELES shows a quite strong growth in Revenue. The Revenue has grown by 8.92% in the last year.
The Revenue has been growing by 15.31% on average over the past years. This is quite good.
EPS 1Y (TTM)64.37%
EPS 3Y4.55%
EPS 5Y0.68%
EPS Q2Q%92.44%
Revenue 1Y (TTM)8.92%
Revenue growth 3Y23.37%
Revenue growth 5Y15.31%
Sales Q2Q%12.03%

3.2 Future

Based on estimates for the next years, ELES will show a very strong growth in Earnings Per Share. The EPS will grow by 45.70% on average per year.
Based on estimates for the next years, ELES will show a quite strong growth in Revenue. The Revenue will grow by 13.61% on average per year.
EPS Next Y50%
EPS Next 2Y52.75%
EPS Next 3Y49.38%
EPS Next 5Y45.7%
Revenue Next Year13.89%
Revenue Next 2Y13.41%
Revenue Next 3Y13.69%
Revenue Next 5Y13.61%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ELES.MI Yearly Revenue VS EstimatesELES.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20M 40M 60M
ELES.MI Yearly EPS VS EstimatesELES.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.05 0.1 0.15 0.2 0.25

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 27.88, the valuation of ELES can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of ELES indicates a somewhat cheap valuation: ELES is cheaper than 61.11% of the companies listed in the same industry.
ELES is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.41, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 24.29, which indicates a rather expensive current valuation of ELES.
ELES's Price/Forward Earnings is on the same level as the industry average.
ELES's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.88.
Industry RankSector Rank
PE 27.88
Fwd PE 24.29
ELES.MI Price Earnings VS Forward Price EarningsELES.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ELES indicates a rather cheap valuation: ELES is cheaper than 90.74% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ELES indicates a rather cheap valuation: ELES is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 6.49
EV/EBITDA 5.88
ELES.MI Per share dataELES.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ELES's earnings are expected to grow with 49.38% in the coming years.
PEG (NY)0.56
PEG (5Y)40.81
EPS Next 2Y52.75%
EPS Next 3Y49.38%

0

5. Dividend

5.1 Amount

ELES does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ELES SEMICONDUCTOR EQUIPMENT

BIT:ELES (9/16/2025, 7:00:00 PM)

2.23

-0.07 (-3.04%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners7.74%
Inst Owner ChangeN/A
Ins Owners31.74%
Ins Owner ChangeN/A
Market Cap38.33M
Analysts82.86
Price Target3.25 (45.74%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-10%
EPS NY rev (3m)-10%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.24%
Valuation
Industry RankSector Rank
PE 27.88
Fwd PE 24.29
P/S 1.07
P/FCF 6.49
P/OCF 6.09
P/B 1.38
P/tB 2.13
EV/EBITDA 5.88
EPS(TTM)0.08
EY3.59%
EPS(NY)0.09
Fwd EY4.12%
FCF(TTM)0.34
FCFY15.41%
OCF(TTM)0.37
OCFY16.42%
SpS2.08
BVpS1.62
TBVpS1.05
PEG (NY)0.56
PEG (5Y)40.81
Profitability
Industry RankSector Rank
ROA 2.24%
ROE 4.47%
ROCE 10.95%
ROIC 6.98%
ROICexc 9.24%
ROICexgc 13.76%
OM 12.08%
PM (TTM) 3.48%
GM 51.4%
FCFM 16.55%
ROA(3y)1.61%
ROA(5y)2.47%
ROE(3y)3.53%
ROE(5y)5.33%
ROIC(3y)4.69%
ROIC(5y)4.15%
ROICexc(3y)6.24%
ROICexc(5y)5.97%
ROICexgc(3y)9.41%
ROICexgc(5y)8.84%
ROCE(3y)7.35%
ROCE(5y)6.52%
ROICexcg growth 3Y38.04%
ROICexcg growth 5Y10.61%
ROICexc growth 3Y34.42%
ROICexc growth 5Y9.58%
OM growth 3Y29.01%
OM growth 5Y12.15%
PM growth 3Y-8.14%
PM growth 5Y-6.16%
GM growth 3Y11.8%
GM growth 5Y5.73%
F-Score9
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 2.75
Debt/EBITDA 1.27
Cap/Depr 12.67%
Cap/Sales 1.08%
Interest Coverage 250
Cash Conversion 85.52%
Profit Quality 475.3%
Current Ratio 2.33
Quick Ratio 1.79
Altman-Z 2.44
F-Score9
WACC10.04%
ROIC/WACC0.69
Cap/Depr(3y)32.99%
Cap/Depr(5y)27.08%
Cap/Sales(3y)2.56%
Cap/Sales(5y)2.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.37%
EPS 3Y4.55%
EPS 5Y0.68%
EPS Q2Q%92.44%
EPS Next Y50%
EPS Next 2Y52.75%
EPS Next 3Y49.38%
EPS Next 5Y45.7%
Revenue 1Y (TTM)8.92%
Revenue growth 3Y23.37%
Revenue growth 5Y15.31%
Sales Q2Q%12.03%
Revenue Next Year13.89%
Revenue Next 2Y13.41%
Revenue Next 3Y13.69%
Revenue Next 5Y13.61%
EBIT growth 1Y38.54%
EBIT growth 3Y59.16%
EBIT growth 5Y29.31%
EBIT Next Year200%
EBIT Next 3Y58.14%
EBIT Next 5Y52.24%
FCF growth 1Y269.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y117.26%
OCF growth 3YN/A
OCF growth 5YN/A